M4MM
Senate Democrats Reintroduce Comprehensive Cannabis Descheduling Bill, Renewing Push for Federal Reform
WASHINGTON, D.C. - The push for comprehensive federal Cannabis reform has returned to the U.S. Senate with the reintroduction of the Cannabis Administration and Opportunity Act (CAOA), a sweeping piece of legislation that would remove ...
California’s Cannabis Promise Remains Unfulfilled: Why Racial Disparities in Cannabis Arrests Continue to Shame the Golden State
SACRAMENTO- Nearly a decade after California voters approved adult-use Cannabis, the state has become one of the world's largest legal Cannabis markets. Billions of dollars have flowed through licensed businesses, thousands of jobs have been ...
FDA Finalizes Psychedelic Drug Guidance and Schedules September Public Hearing
WASHINGTON, D.C., The US FDA has established clearer expectations for psychedelic clinical trials while inviting public input on how the therapies could eventually be delivered in supervised healthcare settings. The U.S. Food and Drug Administration ...
Definium Clears Phase 3 Trial for its LSD-Based Depression Treatment
NEW YORK – Definium Therapeutics Inc. announced positive topline data from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet (ODT) formulation of pharmaceutical LSD, in adults with major depressive disorder (MDD). The ...
Vireo Growth Finalizes Equity Stake in Two Maryland Dispensaries
MINNEAPOLIS – Vireo Growth Inc. announced that it has completed the acquisition of an indirect 49% equity interest in HA-MD, LLC, the entity that owns Chesapeake Integrated Health Institute and Maryland Alternative Relief, two licensed ...
Khalifa Kush Enters Australia Through Endoca Distribution Deal
LOS ANGELES – Khalifa Kush, the Cannabis brand founded by rapper Wiz Khalifa, has struck a distribution agreement with Australian medicinal Cannabis company Endoca to bring its flower, edibles and vape cartridges to patients across ...
Otsuka Completes $1.23B Buyout of Transcend Therapeutics
PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical Co., Ltd., announced that it has completed its acquisition of Transcend Therapeutics, a New York biotechnology company developing rapid-acting treatments for neuropsychiatric disease. First disclosed ...
Senate Democrats Reintroduce Comprehensive Cannabis Descheduling Bill, Renewing Push for Federal Reform
WASHINGTON, D.C. - The push for comprehensive federal Cannabis reform has returned to the U.S. Senate with the reintroduction of the Cannabis Administration and Opportunity Act (CAOA), a sweeping piece of legislation that would remove ...
California’s Cannabis Promise Remains Unfulfilled: Why Racial Disparities in Cannabis Arrests Continue to Shame the Golden State
SACRAMENTO- Nearly a decade after California voters approved adult-use Cannabis, the state has become one of the world's largest legal Cannabis markets. Billions of dollars have flowed through licensed businesses, thousands of jobs have been ...
FDA Finalizes Psychedelic Drug Guidance and Schedules September Public Hearing
WASHINGTON, D.C., The US FDA has established clearer expectations for psychedelic clinical trials while inviting public input on how the therapies could eventually be delivered in supervised healthcare settings. The U.S. Food and Drug Administration ...
FDA Signals Shift to Single Phase 3 Trials for Drug Approvals, Opening Door for Faster Psychedelic Therapies
LOS ANGELES – The Food and Drug Administration is preparing to overhaul its evidence requirements for new drug approvals, making a single well-designed Phase 3 trial the standard rather than the exception. This adjustment, outlined ...
Trulieve Clears $368M Debt with Full Redemption of Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up the buyback of its entire $368 million stack of 8% senior secured notes set to mature in 2026, handing over about $373 million in cash to cover the ...
OPINION: MJBizCon25 Review: The Race To Be Second
LAS VEGAS- Gosh… the MJBizCon I attended was awesome — genuinely one of the best and most productive ones I’ve ever been to — which is why I was so surprised to see how much ...
CRS Reveals Hemp Ban Enforcement Hurdles
WASHINGTON – The Congressional Research Service (CRS) has highlighted gaps in the federal government's plans to enforce the upcoming ban on intoxicating hemp products, raising questions about the practical reach of the law amid the ...
Federal Hemp Overhaul Threatens Cannabis Seed Trade, Sparking Breeder Backlash
LOS ANGELES – A tucked-away clause in last month's federal spending package has upended the rules for Cannabis seeds, thrusting the U.S. genetics sector into uncertainty and prompting warnings from cultivators that prized strains could ...
CMI Projects Double-Digit Expansion for Cannabis Testing Market
LOS ANGELES – A recent analysis from Custom Market Insights (CMI) forecasts the global Cannabis testing market to climb from $2.13 billion in 2025 to $11.15 billion by 2034, powered by a CAGR of 18%. ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past fortnight delivered a surge of momentum across the U.S. Cannabis and Psychedelics sectors, where federal signals on coverage and equity met bold state actions on access and licensing. Operators navigated ...
Psychedelics Advance in Federal Arena as Trials and Policies Align
LOS ANGELES – Federal health officials under the Trump administration have begun to signal stronger backing for psychedelic therapies, setting the stage for possible FDA approvals of MDMA and psilocybin treatments within the next 18 ...
RESPECT: House Lawmakers Introduce Cannabis Equity Resolution
WASHINGTON – A group of eight House lawmakers, led by members of the Congressional Cannabis Caucus, filed a resolution aimed at bolstering fair access to the burgeoning Cannabis sector for communities long sidelined by federal ...
Bipartisan Measure Targets Barriers to Psychedelic Therapies for Terminal Patients
WASHINGTON – A group of House and Senate lawmakers from both parties unveiled legislation to permit physicians to deliver Schedule I substances, including MDMA and psilocybin, to individuals grappling with terminal illnesses or severe mental ...
Curaleaf Opens 70th Dispensary in Florida
STAMFORD – Curaleaf Holdings Inc. added its 70th medical Cannabis dispensary in Florida, targeting patients along the Space Coast with a new location in Cape Canaveral. The store, set for a grand opening on December ...
Aurora Partners with Leafio to Expand Medical Cannabis Reach in Australia
EDMONTON – Aurora Cannabis Inc. disclosed a new wholesale distribution agreement with Leafio, the supply chain arm of Montu Australia, positioning the Canadian producer to channel more of its medical Cannabis lineup into clinics and ...
Curaleaf Secures Virginia Foothold with Purchase of Cannabist Assets
STAMFORD – Curaleaf Holdings, Inc. has entered into an agreement to purchase key Cannabis operations in Virginia from The Cannabist Co. Holdings Inc. for $110 million, marking a calculated move into one of the East ...
Virginia Panel Outlines Path to Regulated Cannabis Sales in 2026
RICHMOND – Members of Virginia's Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market presented a series of amendments to create a licensed system for adult-use Cannabis sales, targeting a ...
Texas Regulator Awards Verano Conditional License to Operate in State’s Medical Cannabis Market
AUSTIN – The Texas Department of Public Safety has issued a conditional license to Verano Texas, LLC, a subsidiary of Verano Holdings Corp., paving the way for the MSO to pursue cultivation, processing, and retail ...
